The UK-based digital therapeutics (DTx), my mhealth, has announced the promotion of Dr David Pettigrew as CEO. David will guide the organisation in its mission to improve the quality of care for people with long-term conditions, through digital health.
Having spent time in the US successfully growing a healthcare technology business for a UK-based company, David is ideally placed to lead my mhealth’s expansion into the US market.
Dr Pettigrew has extensive experience in the digital health industry. Throughout his 17-year career, he has been responsible for managing large and complex digital health product development projects, building new organisational capabilities and for overall business delivery. He was an early pioneer in developing FDA-regulated smartphone apps. Most recently, he led Sagentia, an AIM-listed international technology and product development business, and was part of BrightInsight’s leadership team, focusing on building DTx solutions for the medtech and pharmaceutical industry. David holds a DPhil in Molecular Biophysics from the University of Oxford.
David replaces the founder Simon Bourne, who is transitioning to President and will continue to take an active interest in developing my mhealth’s AI capabilities.
